Nouvelle Ivoire Cosmetique NICOS · 66-41 · IVORY COAST
For Nouvelle Ivoire Cosmetique NICOS, import alert is 66-41; country is IVORY COAST; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is PIMENT Doux plus FACE WHITENING CREAM | PIMENT Doux plus FACE WHITENING CREAM; product code is 53 L - - 06 Moisturizing (Skin Care Preparations) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 04/10/2024; address is 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST, verified against its source on 2026-10-01.
- Firm
- Nouvelle Ivoire Cosmetique NICOS verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- IVORY COAST verified
- Address
- 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST verified
- Date published
- 04/10/2024 verified
- Product code
- 53 L - - 06 Moisturizing (Skin Care Preparations) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- PIMENT Doux plus FACE WHITENING CREAM | PIMENT Doux plus FACE WHITENING CREAM each item verified
- FDA notes
- Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. | Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. each item verified
What the source says
Nouvelle Ivoire Cosmetique NICOS Date Published : 04/10/2024 03 BP 659 Abidjan 03 , Abidjan, IVORY COAST
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
53 L - - 06 Moisturizing (Skin Care Preparations) Date Published: 04/10/2024 Desc: PIMENT Doux plus FACE WHITENING CREAM Notes: Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 04/10/2024 Desc: PIMENT Doux plus FACE WHITENING CREAM Notes: Products appear to be new drugs as defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1). As such, “PIMENT Doux plus FACE WHITENING CREAM” appears to be an unapproved new drug in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introduction or delivery for introduction of “PIMENT Doux plus FACE WHITENING CREAM” into interstate commerce violates sections 301(d) and (a) of the FD&C Act, 21 U.S.C. 331(d) and (a). Based on its labeled intended uses, “PIMENT Doux plus FACE WHITENING CREAM” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended for use as a skin bleaching drug product.
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.